Discontinuation report NOVAMOXIN

Last updated on 2019-04-11 History
Report ID 81321
Drug Identification Number 02036347
Brand name NOVAMOXIN
Common or Proper name AMOXICILLIN
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMOXICILLIN
Strength(s) 125MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 100
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-10-30
Remaining supply date 2019-01-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-04-11 French Compare
v1 2019-04-11 English Compare

Showing 1 to 2 of 2